These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 22465961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhancement in therapeutic efficacy of miltefosine in combination with synthetic bacterial lipopeptide, Pam3Cys against experimental Visceral Leishmaniasis.
    Shakya N, Sane SA, Vishwakarma P, Gupta S.
    Exp Parasitol; 2012 Jul; 131(3):377-82. PubMed ID: 22626518
    [Abstract] [Full Text] [Related]

  • 5. Pravastatin modulates macrophage functions of Leishmania (L.) amazonensis-infected BALB/c mice.
    Kückelhaus CS, Kückelhaus SA, Tosta CE, Muniz-Junqueira MI.
    Exp Parasitol; 2013 May; 134(1):18-25. PubMed ID: 23402845
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifolium.
    Cheng XQ, Li H, Yue XL, Xie JY, Zhang YY, Di HY, Chen DF.
    J Ethnopharmacol; 2010 Jul 20; 130(2):363-8. PubMed ID: 20546871
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination of paromomycin and miltefosine promotes TLR4-dependent induction of antileishmanial immune response in vitro.
    Das S, Rani M, Pandey K, Sahoo GC, Rabidas VN, Singh D, Das P.
    J Antimicrob Chemother; 2012 Oct 20; 67(10):2373-8. PubMed ID: 22761329
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis.
    Santa-Rita RM, Henriques-Pons A, Barbosa HS, de Castro SL.
    J Antimicrob Chemother; 2004 Oct 20; 54(4):704-10. PubMed ID: 15329361
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of liposome-encapsulated ciprofloxacin on phagocytosis, nitric oxide and intracellular killing of Staphylcoccus aureus by murine macrophages.
    Wong JP, Schnell G, Simpson M, Saravolac E.
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Sep 20; 28(5):415-28. PubMed ID: 11009114
    [Abstract] [Full Text] [Related]

  • 16. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity.
    Bhattacharjee S, Gupta G, Bhattacharya P, Mukherjee A, Mujumdar SB, Pal A, Majumdar S.
    J Antimicrob Chemother; 2009 Feb 20; 63(2):317-24. PubMed ID: 19036753
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
    Pereira WK, Lonardoni MV, Grespan R, Caparroz-Assef SM, Cuman RK, Bersani-Amado CA.
    J Infect; 2005 Aug 20; 51(2):157-64. PubMed ID: 16038768
    [Abstract] [Full Text] [Related]

  • 19. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.
    Wadhone P, Maiti M, Agarwal R, Kamat V, Martin S, Saha B.
    J Immunol; 2009 Jun 01; 182(11):7146-54. PubMed ID: 19454711
    [Abstract] [Full Text] [Related]

  • 20. Phagocytosis, endosomal/lysosomal system and other cellularaspects of macrophage activation by Canova medication.
    Lopes L, Godoy LM, de Oliveira CC, Gabardo J, Schadeck RJ, de Freitas Buchi D.
    Micron; 2006 Jun 01; 37(3):277-87. PubMed ID: 16364649
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.